Recall Notice: Pharmacy Level Product Recall of Stimate (desmopressin) Nasal Spray

An important update regarding the pharmacy level product recall of Stimate (desmopressin) nasal spray. Please read if you use Stimate.

We have learned of a pharmacy level product recall of Stimate (desmopressin) nasal spray manufactured by Ferring Pharmaceuticals, and distributed in the U.S. by CSL Behring. Ferring has prepared a Health Hazard Safety Evaluation, warning that “there is a reasonable probability that the use of, or exposure to, certain defective units of this product could pose a significant hazard and may cause adverse health consequences due to increased concentrations of desmopressin.” Patients should not use the product and should contact their physician about changing their treatment regimen. As of mid-July 2020, affected batches of these products have been recalled worldwide.

We recognize that recalls can be very unsettling for many in the bleeding disorders community. NHF and HFA are in communications with CSL Behring with questions about the specifics and timing of the recall. They will publish all written communication and update the community as soon as possible. https://bit.ly/StimateRecall_2020-07-21